BWXT combines 44.2% upside to the analyst target, 28% ROE and a perfect 4-quarter beat streak with a confirmed downtrend, weak cash conversion and leverage, with earnings due in 1 day making a wait-for-the-report stance sensible.
Thesis pillars
- Large Upside To Analyst Target↑Improving
- Perfect Earnings Beat Streak→Stable
- High Returns Weak Cash Conversion→Stable
- +2 more pillars — see the Why tab for full reasoning
Pillars as of Nov 1, 2026, based on the 10-K filed Feb 23, 2026
BWX Technologies, Inc. (BWXT) Stock Analysis
Falling Knife setup
Industrials · Aerospace & Defense
Hold if already holding. Not a fresh buy at $121.50, but acceptable to hold if already in. Reasons: V7 low-quality RISK_OFF penalty: -0.5 (Q=5.4); Sector modifier (Industrials): -0.7.
BWX Technologies manufactures precision naval nuclear components, reactor fuel, and medical radioisotopes across two segments: Government Operations (DOE/NNSA Naval Nuclear Propulsion Program) and Commercial Operations (nuclear power utilities, principally Canada, and life... Read more
Hold if already holding. Not a fresh buy at $121.50, but acceptable to hold if already in. Reasons: V7 low-quality RISK_OFF penalty: -0.5 (Q=5.4); Sector modifier (Industrials): -0.7. Chart setup: Death cross, below all MAs, RSI 31, MACD bearish. Under M&A bid. Hold for deal completion or sell if spread < 3%. Score 5.5/10, high confidence.
Passes 6/8 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, earnings proximity 109d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and death cross (50MA < 200MA). Suitability: speculative.
About BWX Technologies, Inc.
About BWX Technologies, Inc.
BWX Technologies entered 2026 with $7.261 billion in total backlog — $5.541 billion (76%) in Government Operations and $1.720 billion (24%) in Commercial Operations — and expects to recognize approximately 40% of that revenue by year-end 2026. U.S. Government contracts represented approximately 68% of 2025 total consolidated revenues. The company delivers precision naval nuclear components, reactor fuel, medical radioisotopes, and nuclear services from manufacturing facilities across the U.S. and Canada.
Government Operations revenue flows primarily from long-term fixed-price incentive fee contracts with the DOE/NNSA Naval Nuclear Propulsion Program, under which BWX Technologies has supplied nuclear components since the 1950s. Supplementary revenue comes from joint-venture management and operation of DOE nuclear facilities and environmental remediation sites, with partners including Huntington Ingalls Industries, Amentum Environment & Energy, Bechtel National, and Fluor Federal Services. Commercial Operations revenue depends on the cyclical timing of nuclear power plant maintenance outages and life-extension refurbishments, principally in Canada, where the majority of Ontario plants are expected to require refurbishment. The January 2025 acquisition of Aerojet Ordnance Tennessee from L3Harris expanded advanced-materials capabilities, and the May 2025 acquisition of Kinectrics added nuclear lifecycle services and medical isotope production. In commercial nuclear components, primary competitors include Framatome, Doosan Heavy Industries, Westinghouse Electric Corporation, and Cameco Corporation.
Show full overview
BWXT Technologies' revenues are materially dependent on Congressional appropriations and DOE funding levels. The 10-K discloses that budget reductions or a government shutdown could produce program delays, production halts, employee furloughs, and non-payment. Counterbalancing this risk, the U.S. Navy's March 2024 30-year shipbuilding plan — with all three procurement profiles indicating sustained or increased nuclear submarine and aircraft carrier procurement — provides long-horizon visibility that supports the company's expectation that naval nuclear component orders will remain a significant portion of backlog for the foreseeable future.
See also: Industrials · Aerospace & Defense
From BWX Technologies, Inc.'s most recent 10-K filing, extracted June 9, 2026.
Recent developments
updated Nov 1, 2026Recent Developments — BWX Technologies, Inc.
Latest news
- NEWS BWX Technologies Reports Earnings on Nov. 2 2026. Here's What Investors Should Be Watching. - The Motley Fool — The Motley Fool Nov 1, 2026 neutral
- NEWS NuScale Power Rises 7% on Doosan Manufacturing Deal; Oklo and BWX Technologies Trail - 24/7 Wall St. — 24/7 Wall St. Oct 29, 2026 positive
- NEWS BWXT or OKLO: Which Nuclear Stock Should You Choose and Why? - Zacks Investment Research — Zacks Investment Research Oct 28, 2026 neutral
- NEWS BWXT or OKLO: Which Nuclear Stock Should You Choose and Why? - TradingView — TradingView Oct 28, 2026 neutral
- NEWS BWX Technologies (NYSE:BWXT) Stock Forecast & Analyst Predictions - Simply Wall St — Simply Wall St Oct 28, 2026 neutral
Latest item Nov 1, 2026 · Generated 2026-11-05T11:49:09Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
1 floor-breaker
Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $121.50, but acceptable to hold if already in. Reasons: V7 low-quality RISK_OFF penalty: -0.5 (Q=5.4); Sector modifier (Industrials): -0.7. Chart setup: Death cross, below all MAs, RSI 31, MACD bearish. Under M&A bid. Hold for deal completion or sell if spread < 3%. Analyst target $187.60 (+54.4%), stop $116.01 (−4.7%), A.R:R 5.9:1. Score 5.5/10, high confidence.
Analyst target: $187.60 (+54.4% upside). Analyst target $187.60 (+54.4%), stop $116.01 (−4.7%), A.R:R 5.9:1. Stop-loss: $116.01.
V7 low-quality RISK_OFF penalty: -0.5 (Q=5.4); Sector modifier (Industrials): -0.7; Leverage penalty (D/E 1.4): -0.5.
BWX Technologies, Inc. trades at a P/E of 29.9 (forward 23.5). TrendMatrix value score: 6.0/10. Verdict: Hold.
26 analysts rate BWXT, with a consensus score of 4.1/5. 16 analysts publish price targets averaging $208.
What does BWX Technologies, Inc. do?BWX Technologies manufactures precision naval nuclear components, reactor fuel, and medical radioisotopes across two...
BWX Technologies manufactures precision naval nuclear components, reactor fuel, and medical radioisotopes across two segments: Government Operations (DOE/NNSA Naval Nuclear Propulsion Program) and Commercial Operations (nuclear power utilities, principally Canada, and life sciences). U.S. Government contracts comprised approximately 68% of 2025 consolidated revenues, with $7.261 billion in backlog at year-end 2025.